Compliance Rate

Compliance Rate 48.0%
Compliant submissions 48
Incompliant submissions 52
Total trials 100

Your Clinical Trials

Showing 539050 of 542236 entries
View as:

Community Health Worker Based Intervention to Improve Palliative Care

Phase: N/A Priority: Normal
NCT ID: NCT05407844 Org: User:
Start: 11/02/23 End: 09/01/27 Due: 09/01/28

Use of High Dose Radiation Followed by Chemotherapy and Radiation to Treat Locally Advanced NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT03141359 Org: User:
Start: 05/12/17 End: 07/31/27 Due: 07/31/28

IDMet (RaDiCo Cohort) (RaDiCo-IDMet)

Phase: N/A Priority: Normal
NCT ID: NCT05945576 Org: User:
Start: 03/10/17 End: 03/31/28 Due: 03/31/29

Evaluation of Topical ATR12-351 in Adults With Netherton Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT06137157 Org: User:
Start: 06/19/24 End: 08/01/25 Due: 08/01/26

Postoperative Pain Control in Total Shoulder Arthroplasty

Phase: N/A Priority: Normal
NCT ID: NCT05068960 Org: User:
Start: 03/01/21 End: 02/01/25 Due: 02/01/26

Imaging Study of 18F-FAC PET Scans to Assess Standard Treatment in People with Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05141643 Org: User:
Start: 11/18/21 End: 11/18/25 Due: 11/18/26

Safety of Endobronchial Mesenchymal Stromal Cells in the Treatment of Chronic Lung Allograft Dysfunction

Phase: N/A Priority: Normal
NCT ID: NCT06514378 Org: User:
Start: 09/19/23 End: 03/31/26 Due: 03/31/27

Clinical and Diagnostic Features of Endocarditis

Phase: N/A Priority: Normal
NCT ID: NCT05547607 Org: User:
Start: 09/09/22 End: 09/30/26 Due: 09/30/27

Study of the Safety and Efficacy of APR-246 in Combination With Azacitidine

Phase: N/A Priority: Normal
NCT ID: NCT03588078 Org: User:
Start: 09/15/18 End: 05/15/21 Due: 05/15/22

A Digital Intervention for HIV Prevention in Black Adolescent Girls

Phase: N/A Priority: Normal
NCT ID: NCT04108988 Org: User:
Start: 02/01/22 End: 09/24/22 Due: 09/24/23

A Study of Ivosidenib or Enasidenib in Combination With Induction Therapy and Consolidation Therapy, Followed by Maintenance Therapy in Patients With Newly Diagnosed Acute Myeloid Leukemia or Myedysplastic Syndrome EB2, With an IDH1 or IDH2 Mutation, Respectively, Eligible for Intensive Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT03839771 Org: User:
Start: 03/01/19 End: 09/19/34 Due: 09/19/35

In Vivo Metabolism of apoB-containing Lipoproteins in ANGPTL3 Deficient Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05569928 Org: User:
Start: 09/30/22 End: 01/30/25 Due: 01/30/26

Synovitis in Patients With Osteoarthritis

Phase: N/A Priority: Normal
NCT ID: NCT05617573 Org: User:
Start: 11/01/20 End: 12/31/22 Due: 12/31/23

Almond Butter and Fasting Glucose

Phase: N/A Priority: Normal
NCT ID: NCT03826472 Org: User:
Start: 03/08/19 End: 03/01/20 Due: 03/01/21

Weaning of Immunosuppression in Nephritis of Lupus

Phase: N/A Priority: Normal
NCT ID: NCT01284725 Org: User:
Start: 01/31/11 End: 08/31/21 Due: 08/31/22

The Effect of Oral Candidiasis on the Speech Production, Feeding Skills, and Self-Concept of Children and Adolescents With Symptomatic HIV Infection

Phase: N/A Priority: Normal
NCT ID: NCT00001448 Org: User:
Start: 08/31/95 End: 06/30/00 Due: 06/30/01

Global Physiotherapy in ICU Patients With High Risk Extubation Failure

Phase: N/A Priority: Normal
NCT ID: NCT05423301 Org: User:
Start: 09/15/23 End: 10/31/25 Due: 10/31/26

Locobase® REPAIR Used as an Adjunctive to Standard Therapy in Children With Moderate to Severe Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT00673725 Org: User:
Start: 03/31/08 End: 09/30/08 Due: 09/30/09

Effect of Different Non-surgical Treatment Approaches of Peri-implantitis

Phase: N/A Priority: Normal
NCT ID: NCT06730568 Org: User:
Start: 11/27/17 End: 06/04/18 Due: 06/04/19

Adebrelimab Combined with Irinotecan Liposomes, 5-FU, CF ± Lenvatinib As First-line Treatment for Advanced ICC

Phase: N/A Priority: Normal
NCT ID: NCT06648525 Org: User:
Start: 10/31/24 End: 04/30/28 Due: 04/30/29

Evaluation of University Students' Knowledge Levels and Perceptions of the Physiotherapist

Phase: N/A Priority: Normal
NCT ID: NCT05190822 Org: User:
Start: 12/20/21 End: 05/30/22 Due: 05/30/23

Efficacy and Safety of Canakinumab in Schnitzler Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT01276522 Org: User:
Start: 01/31/11 End: 12/31/11 Due: 12/31/12

Losartan in Treating Pulmonary Fibrosis in Patients With Stage I, II, or III Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00880386 Org: User:
Start: 03/31/09 End: 04/30/10 Due: 04/30/11

Predicting Relapse After Cocaine Inpatient Cessation

Phase: N/A Priority: Normal
NCT ID: NCT02416050 Org: User:
Start: 02/03/15 End: 01/03/22 Due: 01/03/23

Safety and Immunogenicity of COVID-19 Vaccine, AdCLD-CoV19-1

Phase: N/A Priority: Normal
NCT ID: NCT05520970 Org: User:
Start: 08/19/22 End: 11/08/22 Due: 11/08/23